Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment

• SHIRAKI Masataka

  Research Institute and Practice for Involutional Diseases

• KURODA Tatsuhiko

  Public Health Research Foundation

• SHIRAKI Yumiko

  Research Institute and Practice for Involutional Diseases

• TANAKA Shiro

  Division of Clinical Trial, Design and Management, Translational Research Center, Kyoto University

• HIGUCHI Tsuyoshi

  Department of Obstetrics and Gynecology, Hirosaki University School of Medicine

• SAITO Mitsuru

  Department of Orthopedic Surgery, Jikei University School of Medicine

収録刊行物

• Journal of bone and mineral metabolism

  Journal of bone and mineral metabolism 29 (1), 62-70, 2011-01-30

キーワード

• Pentosidine
• Homocysteine
• Bisphosphonates
• Osteoporosis
• Fracture

詳細情報

• CRID: 1571135649997026304
• NII論文ID: 10029023713
• NII書誌ID: AA10747551
• ISSN: 09148779
• Web Site: https://search.jamas.or.jp/link/ui/2011323206
• 本文言語コード: en
• データソース種別:
  • CiNii Articles